Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin S Tallman

Showing results (1-10 of 509) with videos related to

Pageof 51
Sort By:
Seminars in Hematology|November 26, 2002
Advancing the treatment of hematologic malignancies through the development of targeted interventionsMartin S Tallman
Reviews in Clinical and Experimental Hematology|June 26, 2003
Current treatment strategies for patients with hairy cell leukemiaMartin S Tallman
Cancer Treatment and Research|June 26, 2004
Relevance of pathologic classifications and diagnosis of acute myeloid leukemia to clinical trials and clinical practiceMartin S Tallman
Best Practice & Research. Clinical Haematology|September 26, 2006
Immune therapy in haematological malignanciesMartin S Tallman
Leukemia & Lymphoma|April 6, 2011
Implications of minimal residual disease in hairy cell leukemia after cladribine using immunohistochemistry and immunophenotypingMartin S Tallman
Hematology. American Society of Hematology. Education Program|December 17, 2008
Acute myeloid leukemia; decided victories, disappointments, and detente: an historical perspectiveMartin S Tallman
Leukemia & Lymphoma|April 29, 2010
All-trans retinoic acid and arsenic rescue patients with acute promyelocytic leukemia from a potential 'perfect storm'Martin S Tallman
Best Practice & Research. Clinical Haematology|March 7, 2006
New agents for the treatment of acute myeloid leukemiaMartin S Tallman
Hematology. American Society of Hematology. Education Program|November 24, 2005
New strategies for the treatment of acute myeloid leukemia including antibodies and other novel agentsMartin S Tallman
Clinical Advances in Hematology & Oncology : H&O|November 1, 2005
Current management and new approaches in the treatment of APLMartin S Tallman
Pageof 51

Showing results (1-10 of 509) with videos related to

Sort By:
Pageof 51
Seminars in Hematology|November 26, 2002
Advancing the treatment of hematologic malignancies through the development of targeted interventionsMartin S Tallman
Reviews in Clinical and Experimental Hematology|June 26, 2003
Current treatment strategies for patients with hairy cell leukemiaMartin S Tallman
Cancer Treatment and Research|June 26, 2004
Relevance of pathologic classifications and diagnosis of acute myeloid leukemia to clinical trials and clinical practiceMartin S Tallman
Best Practice & Research. Clinical Haematology|September 26, 2006
Immune therapy in haematological malignanciesMartin S Tallman
Leukemia & Lymphoma|April 6, 2011
Implications of minimal residual disease in hairy cell leukemia after cladribine using immunohistochemistry and immunophenotypingMartin S Tallman
Hematology. American Society of Hematology. Education Program|December 17, 2008
Acute myeloid leukemia; decided victories, disappointments, and detente: an historical perspectiveMartin S Tallman
Leukemia & Lymphoma|April 29, 2010
All-trans retinoic acid and arsenic rescue patients with acute promyelocytic leukemia from a potential 'perfect storm'Martin S Tallman
Best Practice & Research. Clinical Haematology|March 7, 2006
New agents for the treatment of acute myeloid leukemiaMartin S Tallman
Hematology. American Society of Hematology. Education Program|November 24, 2005
New strategies for the treatment of acute myeloid leukemia including antibodies and other novel agentsMartin S Tallman
Clinical Advances in Hematology & Oncology : H&O|November 1, 2005
Current management and new approaches in the treatment of APLMartin S Tallman
Pageof 51